Scholay

学术搜索 · AI 审稿 · LaTeX 协作

P. Dorinsky

发表论文 232 篇 · 总被引 5805 次 · h-index 35

代表论文

  • Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial (2021 · Therapeutic Advances in Respiratory Disease · 被引 29)
  • Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS (2022 · International Journal of COPD · 被引 25)
  • Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial. (2021 · Respiratory Medicine · 被引 24)
  • Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS (2021 · International Journal of COPD · 被引 17)
  • A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease (2021 · Respiratory Research · 被引 15)
  • Relationship between prior inhaled corticosteroid use and benefits ofbudesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study. (2022 · Respiratory Medicine · 被引 13)